Catabasis Pharmaceuticals, Inc. - Special Call Transcript
Let's go ahead and get started. Good morning, everyone. Hello, I'm Jill Milne, the Co-Founder and CEO of Catabasis Pharmaceuticals. Welcome to our Duchenne muscular dystrophy and edasalonexent focused event. We're pleased to have you join us today. Before we get started on this sad but patriotic day, September 11, 2020, we would like to acknowledge and remember those that were lost on this date 19 years ago.
Today's event is being recorded. It will be available for replay on the Investor Relations section of the Catabasis website after the event. At the end of today's presentation, we will be hosting a live Q&A session. Please feel free to submit questions throughout the event using the ask a question box on your screen.
During this morning's discussion, you can read the full forward-looking statements by accessing this presentation on our website. I'm pleased to introduce our speakers for today. We are joined by 2 individuals deeply connected to the Duchenne community: Dr. Craig McDonald, an
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |